Literature DB >> 21752352

A polymorphism of the CREB binding protein (CREBBP) gene is a risk factor for addiction.

Deepak Kumar1, Ishani Deb, Japashish Chakraborty, Sikha Mukhopadhyay, Sumantra Das.   

Abstract

Unequivocal evidences have implicated c-AMP response element binding protein (CREB) in drug addiction. Recent reports indicate that the CREB binding protein (CREBBP), a transcription co-activator, may also be involved in the sensitivity to drugs of abuse. We undertook studies on the single nucleotide polymorphisms (SNP) at selective areas of CREBBP gene in heroin as well as in alcohol addicts and compared them with that in normal population. One hundred fifty healthy controls, one hundred thirty heroin addict and one hundred ten alcohol addicts, all males, Bengali-Hindu, and residing in Kolkata, a city in eastern India, participated in the study. DNA prepared from blood drawn from the subjects was PCR amplified for the regions corresponding to exon 3 and 22 of CREBBP gene followed by sequencing. Three SNPs identified in the population were analyzed to find out the association of these SNPs with addiction. One SNP, rs3025684 in intron 21 having the contig position of 3795363, showed association with addiction. The genotype frequencies of the SNP were significantly different between opioid dependent cases and controls (χ(2)=20.28, p<0.0001) as well as between alcoholics and controls (χ(2)=13.60, p=0.0011). Our studies suggest that rs3025684 polymorphism may be a possible risk factor for developing addiction.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752352     DOI: 10.1016/j.brainres.2011.05.048

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  When a TRP goes bad: transient receptor potential channels in addiction.

Authors:  Seth A Wescott; Manish Rauthan; X Z Shawn Xu
Journal:  Life Sci       Date:  2012-07-20       Impact factor: 5.037

2.  The molecular neurobiology and neuropathology of opioid use disorder.

Authors:  Christopher A Blackwood; Jean Lud Cadet
Journal:  Curr Res Neurobiol       Date:  2021-10-14

3.  Antisense-induced knockdown of cAMP response element-binding protein downregulates Per1 gene expression in the shell region of nucleus accumbens resulting in reduced alcohol consumption in mice.

Authors:  Rishi Sharma; Vaibhav Mishra; Meet Parikh; Anshul Soni; Pradeep Sahota; Mahesh Thakkar
Journal:  Alcohol Clin Exp Res       Date:  2021-08-23       Impact factor: 3.928

4.  Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.

Authors:  Cielito C Reyes-Gibby; Christine Yuan; Jian Wang; Sai-Ching J Yeung; Sanjay Shete
Journal:  BMC Syst Biol       Date:  2015-06-05

5.  Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression.

Authors:  Yi Jin; Yanjie Tan; Lupeng Chen; Yan Liu; Zhuqing Ren
Journal:  Int J Mol Sci       Date:  2018-11-02       Impact factor: 5.923

6.  Genetic polymorphism and transcriptional regulation of CREBBP gene in patient with diffuse large B-cell lymphoma.

Authors:  Haifeng Zhao; Yutian Kan; Xinyuan Wang; Leiyuan Chen; Peng Ge; Zhengzi Qian
Journal:  Biosci Rep       Date:  2019-08-13       Impact factor: 3.840

7.  Genome-wide association study identifies a potent locus associated with human opioid sensitivity.

Authors:  D Nishizawa; K Fukuda; S Kasai; J Hasegawa; Y Aoki; A Nishi; N Saita; Y Koukita; M Nagashima; R Katoh; Y Satoh; M Tagami; S Higuchi; H Ujike; N Ozaki; T Inada; N Iwata; I Sora; M Iyo; N Kondo; M-J Won; N Naruse; K Uehara-Aoyama; M Itokawa; M Koga; T Arinami; Y Kaneko; M Hayashida; K Ikeda
Journal:  Mol Psychiatry       Date:  2012-11-27       Impact factor: 15.992

8.  SWI/SNF complexes act through CBP-1 histone acetyltransferase to regulate acute functional tolerance to alcohol.

Authors:  Laura D Mathies; Jonathan H Lindsay; Amal P Handal; GinaMari G Blackwell; Andrew G Davies; Jill C Bettinger
Journal:  BMC Genomics       Date:  2020-09-21       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.